Last reviewed · How we verify

NCT06590441

Investigation of Wearing Compliance of Spectacles for Myopia Control

Completed Results posted Last updated 25 November 2025
What this trial tests

trial testing Myopia control spectacles in Myopia in 53 participants. Completed in 18 January 2025.

Timeline
30 September 2024
Primary endpoint
18 January 2025
18 January 2025

Quick facts

Lead sponsorCooperVision, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment53
Start date30 September 2024
Primary completion18 January 2025
Estimated completion18 January 2025
Sites4 locations across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

CooperVision, Inc.

Who can join

Adults 6 to 15, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Overall Wearing Pattern of Myopia Control Spectacles Primary · Measured continuously over 1 week of wear

Overall wearing patterns were evaluated via the use of temperature sensors fitted to the frame of the spectacles. The temperature readings from the final week of the one month study were used to determine when spectacles were worn or removed. Scores were calculated as the average times over a 24 hour period (W24) where a higher score indicated that the spectacles were worn for a longer period of time per day.

GroupValue95% CI
Myopia Control Spectacles12.8± 4.1
Effect of Sex on Overall Wearing Pattern Primary · Measured continuously over 1 week of wear

The effect of sex on the overall wearing pattern was evaluated via the use of temperature sensors fitted to the frame of the spectacles. The temperature readings from the final week of the one month study were used to determine when spectacles were worn or removed. Scores were calculated as the average times over a 24 hour period (W24) and a 'waking day' period of 07:00 to 21:00 (W14), where a higher score indicated that the spectacles were worn for a longer period of time per day.

W14
GroupValue95% CI
Female Participants1211.0 – 13.0
Male Participants10.49.2 – 11.5
W24
GroupValue95% CI
Female Participants13.912.6 – 15.1
Male Participants11.510.1 – 12.9

Sponsor's own description

The goal of this observational study was to compare the wearing patterns of spectacles prescribed for myopia control in juvenile wearers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Myopia control spectacles

Trials testing the same drug.

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other CooperVision, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06590441.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing